Royce & Associates’s ReposiTrak TRAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-120,707
Closed -$2.37M 828
2025
Q2
$2.37M Hold
120,707
0.02% 576
2025
Q1
$2.45M Buy
120,707
+11,000
+10% +$227K 0.03% 560
2024
Q4
$2.43M Buy
109,707
+82,797
+308% +$1.75M 0.02% 601
2024
Q3
$497K Buy
+26,910
New +$490K ﹤0.01% 799
2015
Q4
Sell
-3,000
Closed -$32K 1177
2015
Q3
$32K Hold
3,000
﹤0.01% 1176
2015
Q2
$37K Hold
3,000
﹤0.01% 1194
2015
Q1
$41K Hold
3,000
﹤0.01% 1202
2014
Q4
$27K Buy
+3,000
New +$26.3K ﹤0.01% 1290

Other funds holding TRAK

Royce & Associates's TRAK Position: Q3 2025 in Review

Royce & Associates sold out of ReposiTrak (TRAK) in Q3 2025, closing a stake of 120,707 shares — an estimated $2.37M sold.

Royce & Associates first reported a position in TRAK in Q4 2014 and held it in 8 quarters. The position peaked at $2.45M in Q1 2025. 91 funds tracked by Wall St. Rank hold TRAK as of Q3 2025.

  • Royce & Associates reported no remaining ReposiTrak position as of Q3 2025 after selling out during the quarter.
  • Royce & Associates sold 120,707 ReposiTrak shares in Q3 2025, an estimated $2.37M.
  • Royce & Associates first reported a position in ReposiTrak in Q4 2014 and held it in 8 quarters.
  • Royce & Associates's ReposiTrak position peaked at $2.45M in Q1 2025.
  • 91 funds tracked by Wall St. Rank held ReposiTrak as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.